Milestones

The Centres of Excellence for Commercialization and Research framework (CECR) enabled PC-TRIADD to build a solid foundation and gain momentum toward it’s objective.

• Attracted over $9 million in research contracts to date, through the structuring of our core platforms to form an integrated contract research enterprise
• Expanded High Quality Personnel and management to include an experienced executive team and a world renowned cancer genetics scientist
• Expanded our portfolio of IP protected targets and drug candidates that tackle treatment resistance that are translating into commercialization activities
• Attracted increased global funding allowing us to initiate 13 new clinical trials in our first year, the majority of which are either peer reviewed, grant funded or are sponsored by pharmaceutical companies
• Hired 19 new research trainees